Should we ban B6 supplementation of INH therapy in childhood tuberculosis?

Autor:	Mathur S, G. P. Mathur, S. Rastogi
Rok vydání:	1993
Předmět:	medicine.medical_specialty Tuberculosis Protein-Energy Malnutrition chemistry.chemical_compound Risk Factors Internal medicine Isoniazid medicine Humans heterocyclic compounds Xanthurenic acid Child Developing Countries Tuberculosis Pulmonary Childhood tuberculosis business.industry Peripheral Nervous System Diseases Pyridoxine biochemical phenomena metabolism and nutrition respiratory system bacterial infections and mycoses medicine.disease respiratory tract diseases Surgery chemistry Pediatrics Perinatology and Child Health Drug Therapy Combination Rifampin Vitamin B 6 Deficiency business Kynurenine
Zdroj:	The Indian Journal of Pediatrics. 60:717-719
ISSN:	0973-7693 0019-5456
DOI:	10.1007/bf02751037
Popis:	INH-vitamin B6 combinations should therefore be banned, and manufacturers should be requested to withdraw such products from the market. Physicians are also requested not to prescribe drugs containing INH with B6.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ed31cde0ab527a3798a683fd194087 https://doi.org/10.1007/bf02751037 Zobrazit plný text záznamu Full text from SpringerLink